FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, which may be useful as a THR receptor agonistβ. In formula (I), R1 is selected from the group consisting of hydrogen, cyano and C1-6 alkyl; R2 and R3 are each an independently selected halogen; ring A is a substituted or unsubstituted C5-10 aromatic ring, where the substituent is selected from the group consisting of hydrogen, halogen and C1-6 alkyl; and the halogen is selected from the group consisting of F, Cl and Br.
EFFECT: invention also relates to a pharmaceutical composition containing the said compound and its use for the manufacture of a therapeutic medicinal product for a thyroid hormone receptor beta-related metabolic disease.
(I)
21 cl, 3 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HALOGEN-SUBSTITUTED PHENYLATE COMPOUND AND USE THEREOF | 2020 |
|
RU2820475C2 |
| METHOD OF SYNTHESIS OF ANALOGUES OF HORMONES OF THE THYROID GLAND AND THEIR POLYMORPHS | 2013 |
|
RU2668960C2 |
| METHOD FOR SYNTHESIS OF THYROID HORMONE ANALOGUES AND THEIR POLYMORPHS | 2021 |
|
RU2802282C2 |
| TRIAZINE DERIVATIVES, METHODS OF THEIR SYNTHESIS, ANTIPROTOZOAN COMPOSITION, ADDITION TO ANIMAL FOOD, METHOD OF INHIBITION OF PROTOZOAN INFECTION IN ANIMALS | 1994 |
|
RU2146674C1 |
| PYRIDASINONE DERIVATIVES AS AGONISTS OF THYROID HORMONE RECEPTOR | 2006 |
|
RU2379295C2 |
| SUBSTITUTED 3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2720305C1 |
| DIAZEPINEINDOLES ARE PHOSPHODIASTERASE-IV INHIBITORS | 1995 |
|
RU2174517C2 |
| PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS TAM AND MET KINASE INHIBITORS | 2019 |
|
RU2773611C1 |
| PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF | 2014 |
|
RU2674977C2 |
| PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
